Susquehanna International Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,700
Closed -$160K 12750
2025
Q1
$160K Buy
+10,700
New +$179K ﹤0.01% 11166
2024
Q4
Sell
-67,300
Closed -$1.25M 12286
2024
Q3
$1.25M Buy
67,300
+10,100
+18% +$203K ﹤0.01% 6309
2024
Q2
$1.16M Sell
57,200
-55,300
-49% -$979K ﹤0.01% 6236
2024
Q1
$1.92M Buy
112,500
+59,900
+114% +$942K ﹤0.01% 5438
2023
Q4
$929K Buy
52,600
+35,200
+202% +$709K ﹤0.01% 7161
2023
Q3
$418K Buy
17,400
+2,300
+15% +$56.5K ﹤0.01% 8650
2023
Q2
$351K Sell
15,100
-14,500
-49% -$328K ﹤0.01% 9119
2023
Q1
$653K Buy
+29,600
New +$693K ﹤0.01% 7910
2022
Q4
Sell
-10,600
Closed -$143K 12529
2022
Q3
$143K Sell
10,600
-18,100
-63% -$305K ﹤0.01% 11302
2022
Q2
$569K Sell
28,700
-31,300
-52% -$832K ﹤0.01% 7941
2022
Q1
$1.9M Buy
60,000
+24,800
+70% +$695K ﹤0.01% 5595
2021
Q4
$785K Buy
35,200
+7,300
+26% +$190K ﹤0.01% 7927
2021
Q3
$774K Sell
27,900
-36,400
-57% -$1.11M ﹤0.01% 8222
2021
Q2
$2.5M Buy
64,300
+29,000
+82% +$1.04M ﹤0.01% 5413
2021
Q1
$1.02M Sell
35,300
-36,200
-51% -$1.24M ﹤0.01% 7701
2020
Q4
$1.9M Sell
71,500
-25,200
-26% -$515K ﹤0.01% 5215
2020
Q3
$1.48M Sell
96,700
-11,500
-11% -$241K ﹤0.01% 5211
2020
Q2
$2.2M Buy
108,200
+82,700
+324% +$1.48M ﹤0.01% 4321
2020
Q1
$264K Sell
25,500
-15,300
-38% -$428K ﹤0.01% 8213
2019
Q4
$1.54M Buy
40,800
+1,800
+5% +$80.9K ﹤0.01% 4754
2019
Q3
$1.82M Sell
39,000
-9,500
-20% -$442K ﹤0.01% 4404
2019
Q2
$2.54M Sell
48,500
-13,100
-21% -$768K ﹤0.01% 3727
2019
Q1
$4.25M Buy
61,600
+47,700
+343% +$3.2M ﹤0.01% 2652
2018
Q4
$829K Sell
13,900
-86,600
-86% -$7.47M ﹤0.01% 5044
2018
Q3
$11.6M Sell
100,500
-3,100
-3% -$350K ﹤0.01% 1781
2018
Q2
$13.1M Buy
103,600
+6,700
+7% +$815K ﹤0.01% 1678
2018
Q1
$10.5M Buy
96,900
+40,500
+72% +$4.48M ﹤0.01% 1727
2017
Q4
$6.18M Buy
56,400
+23,600
+72% +$2.36M ﹤0.01% 2306
2017
Q3
$3.24M Sell
32,800
-10,700
-25% -$1.04M ﹤0.01% 3115
2017
Q2
$4.41M Sell
43,500
-49,300
-53% -$5.32M ﹤0.01% 2579
2017
Q1
$10.7M Sell
92,800
-34,900
-27% -$4.06M 0.01% 1561
2016
Q4
$15.3M Sell
127,700
-14,900
-10% -$1.65M 0.01% 1240
2016
Q3
$16M Buy
142,600
+26,700
+23% +$3.08M 0.01% 1178
2016
Q2
$14.4M Sell
115,900
-114,400
-50% -$13.8M 0.01% 1183
2016
Q1
$25.9M Sell
230,300
-9,400
-4% -$977K 0.01% 831
2015
Q4
$26.1M Buy
239,700
+8,900
+4% +$1.02M 0.01% 955
2015
Q3
$23M Buy
230,800
+101,600
+79% +$11.1M 0.01% 1092
2015
Q2
$14.7M Sell
129,200
-13,600
-10% -$1.65M 0.01% 1602
2015
Q1
$14.9M Buy
142,800
+88,100
+161% +$9.39M 0.01% 1496
2014
Q4
$6.58M Sell
54,700
-40,800
-43% -$5.36M ﹤0.01% 2493
2014
Q3
$14M Sell
95,500
-1,300
-1% -$201K 0.01% 1750
2014
Q2
$16.2M Buy
96,800
+67,700
+233% +$12M 0.01% 1586
2014
Q1
$5.78M Sell
29,100
-6,100
-17% -$1.15M ﹤0.01% 2696
2013
Q4
$6.72M Sell
35,200
-700
-2% -$130K ﹤0.01% 2530
2013
Q3
$6.08M Sell
35,900
-7,400
-17% -$1.15M ﹤0.01% 2461
2013
Q2
$6.57M Buy
+43,300
New +$6.14M ﹤0.01% 2272

Other funds holding CLB

Susquehanna International Group's CLB Position: Q1 2026 in Review

Susquehanna International Group increased its Core Laboratories (CLB) stake by 56% in Q1 2026, buying an estimated $209K and bringing the position to 32,350 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #9447.

Susquehanna International Group first reported a position in CLB in Q2 2013 and has held it in 46 quarters since. The position peaked at $16.9M in Q3 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Susquehanna International Group held 32,350 shares of Core Laboratories worth $543K as of Q1 2026.
  • Susquehanna International Group bought 11,657 Core Laboratories shares in Q1 2026, an estimated $209K.
  • Core Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9447 holding.
  • Susquehanna International Group first reported a position in Core Laboratories in Q2 2013 and has held it in 46 quarters since.
  • Susquehanna International Group's Core Laboratories position peaked at $16.9M in Q3 2014.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.